Bailard’s Esperion Therapeutics ESPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-10,000
Closed -$212K 727
2021
Q2
$212K Sell
10,000
-13,000
-57% -$313K 0.01% 660
2021
Q1
$645K Hold
23,000
0.02% 333
2020
Q4
$598K Sell
23,000
-75,500
-77% -$2.26M 0.03% 289
2020
Q3
$3.66M Hold
98,500
0.19% 98
2020
Q2
$5.05M Buy
98,500
+5,200
+6% +$218K 0.28% 77
2020
Q1
$2.94M Buy
93,300
+3,400
+4% +$179K 0.21% 95
2019
Q4
$5.36M Sell
89,900
-1,000
-1% -$45K 0.3% 78
2019
Q3
$3.33M Buy
90,900
+14,700
+19% +$582K 0.2% 106
2019
Q2
$3.54M Buy
76,200
+16,700
+28% +$784K 0.22% 99
2019
Q1
$2.39M Buy
59,500
+50,500
+561% +$2.27M 0.15% 140
2018
Q4
$414K Hold
9,000
0.03% 340
2018
Q3
$399K Hold
9,000
0.02% 423
2018
Q2
$353K Sell
9,000
-50,300
-85% -$2.54M 0.02% 429
2018
Q1
$4.29M Sell
59,300
-16,000
-21% -$1.17M 0.27% 91
2017
Q4
$4.96M Buy
75,300
+12,000
+19% +$646K 0.31% 71
2017
Q3
$3.17M Hold
63,300
0.25% 103
2017
Q2
$2.93M Buy
63,300
+22,300
+54% +$820K 0.24% 103
2017
Q1
$1.45M Buy
+41,000
New +$939K 0.12% 149
2016
Q1
Sell
-9,000
Closed -$200K 283
2015
Q4
$200K Buy
+9,000
New +$227K 0.09% 191

Other funds holding ESPR